AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

StockNews.com upgraded shares of Novo Nordisk A/S (NYSE:NVO – Free Report) from a buy rating to a strong-buy rating in a report released on Thursday. A number of other analysts have also recently ...

Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...

More GLP-1 news: Roche takes big step in weight-loss field with $5.3 billion deal. Novo Nordisk shares fall. More companies coverage: -- Wells Fargo's stock dips even as analyst proclaims 'good entry ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

FRANKFURT: European shares closed slightly lower on Thursday after US President Donald Trump threatened to impose tariffs on ...

The pan-European Stoxx 600 edged down 0.2 per cent. Spirit-makers Pernod Ricard and Campari fell 4 per cent and 4.3 percent ...

European stocks dipped in volatile trading, with beverage makers sliding after US President Donald Trump threatened to put a ...

EUROPEAN shares closed slightly lower on Thursday after US President Donald Trump threatened to impose tariffs on alcoholic ...

Learn the value of AI transformation and how three Microsoft AI platforms, including Microsoft Copilot, boost productivity in this Microsoft Cloud blog.

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...